The data speaks in a clear voice and it speaks a simple

New Post Public Reply Private Reply Replies (2) Message Board
Bhawks
Quote:
The data speaks in a clear voice and it speaks a simple message: the Republican Party can have Donald Trump or it can have a future, but it cannot have both.


http://thefederalist.com/2016/02/22/why-donal...ite-house/

Quote:
Voting propensity is strongly correlated with educational attainment. The more educated one is, the more likely one is to vote.

Unsurprisingly, therefore, the two most reliable voting groups in the United States are voters with bachelor’s degrees and those with post-graduate degrees. The following chart, drawn from the 2012 election review by the Census Bureau’s Current Population Survey, shows that these two groups turned out at rates of 75 percent and 81 percent, respectively.

Even those who attended but did not finish college had a voting rate higher than 60 percent. The rate for high school graduates was just over 50 percent, and it declined sharply for those who did not finish high school.

Mehta4.jpg


There is simply no way a candidate can win a presidential election now by losing the biggest turnout group by ten or more points, as polls consistently show Trump doing.

College graduates cannot stand Trump, and this surely is no small factor in him having the highest negative rating of any presidential candidate Gallup has ever tested. Sixty percent of Americans have an unfavorable view of Trump. That kind of radioactivity usually requires a Geiger counter to measure.

College graduates vote more, and there are more of them who vote. According to the 2012 exit polls, 47 percent of voters had at least a four-year degree. Another 29 percent spent at least some time enrolled on campus. That adds up to 76 percent. The overlap is not perfect, but if working-class voters are defined as voters with no more than a high school education, then Trump’s hopes rest on taking larger and larger bites from a cherry.

Evidence Trump Haters Won’t Switch Sides

A Trump backer might rejoin that I am merely speculating that college-educated Republicans would not flock to Trump if he became the nominee. Supporters of one candidate during a primary often say they won’t support his opponent but rally around the party flag for the general election. This is a fair point. It is hard to prove a negative,
especially one that hasn’t happened yet.

There is some evidence, however, to indicate Trump may not benefit from this normal pattern.

There are few analogues to Trump in recent years. One who resembled the magnate, at least in his capacity for intemperate remarks, was Todd Akin. In the last poll conducted before he devoured his leg, Akin led his 2012 Missouri Senate race against incumbent Claire McCaskill by 11 points.

This included a one-point advantage with college graduates, 46 to 45 percent. Yet on Election Day, Akin lost college graduates 50 to 44 percent, a seven-point swing. Moreover, 15 percent of Republican voters defected and voted for McCaskill.

Another GOP Senate candidate who made foolish remarks about abortion in 2012 was Richard Mourdock of Indiana. He managed to win college-educated voters, but like Akin he bled considerable Republican support: 14 percent of Hoosier Republicans backed Democrat Joe Donnelly, who won.

In 2010, Sharron Angle, the controversial GOP Senate nominee in Nevada, lost 11 percent of Republicans to Harry Reid. Her Colorado counterpart, Ken Buck, saw 10 percent of Republicans shift to Michael Bennett.

Most instructive, perhaps, is the 2008 presidential election, which saw Barack Obama win 9 percent of Republicans and an astounding 20 percent of self-described conservatives.

Given the aspirational qualities of Obama’s candidacy, we should not be surprised he had so much cross-ballot appeal. Nine or 10 percent is not much in a decisive contest like his first presidential campaign, but in a close election or a swing state it could be the difference between victory and defeat.

Donald Trump Means the End of the Republican Party

Trump doesn’t make inflammatory comments about rape or abortion. That’s because he’s too busy making them about everything else: immigration, foreign policy, economics, his rivals, journalists, you name it. His peanut gallery roars, but the rest of the country is unimpressed.

A Trump-inspired descent into white identity politics would be a cataclysm for the GOP because it would alienate the very voters it needs if it wants the White House back. It must get at least a few voters for whom cultural affinity outweighs partisan affiliation. There is no way to win without them. Trump’s campaign, on the other hand, depends on pursuing voters who don’t exist at the cost of those who do.

It is well and good to appeal to the working class. It behooves the GOP to do so. There is great merit in criticizing the GOP and its leadership and policy cadres, which often seem to care about little more than hunting such mythical beasts as the flat tax while pretending to pay lip service to any number of causes dear to its rank and file.

I have myself avowed that the GOP establishment (and donor class) deserve “incineration.” But Trump should not be the instrument of vengeance. For that sword, once drawn, will be sheathed only with difficulty.

By now you have surely begun to suspect that I oppose Trump. You’re right. I oppose him on philosophical and ideological grounds.

But I also oppose him for practical reasons. Nominate Trump, and the GOP would lose college-educated voters for at least a generation, and possibly forever.

With them would go the prospect of ever again winning states like Colorado, Pennsylvania, Ohio, and Florida. So, without them, would the GOP be finished as a national party, and perhaps as any kind of party at all.

The data speaks in a clear voice and it speaks a simple message: the Republican Party can have Donald Trump or it can have a future, but it cannot have both.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 59

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 38

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Genesys Celebrates Global Recognition as a Top Workplace

Updated Category News Views 50

Genesys Achieves Global Recognition for Workplace Excellence Genesys, a renowned leader in AI-driven experience orchestration, has been proudly certified as a Great Place to Work. This significant accomplishment reflects the overwhelming sentiment from its employees, with a remarkable 90% affirming that Genesys is indeed a fantastic workplace. This statistic represents a...

Continue Reading
Class Action Alert for Twitter Stockholders: Important Updates

Updated Category News Views 198

Understanding the Class Action Lawsuit for Twitter, Inc. Stockholders A significant class action lawsuit has been initiated for individuals and entities who traded Twitter, Inc. stock or options during a specified period. This legal action has garnered substantial attention as it affects numerous investors who believe they suffered losses due to alleged misconduct. Key...

Continue Reading
Rhythm Pharmaceuticals Advances IMCIVREE® for Young Patients

Updated Category News Views 180

Rhythm Pharmaceuticals Receives FDA Acceptance for Priority Review Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company, has announced that the FDA has accepted its supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide). This application has been designated for Priority Review by the FDA, which suggests that patients may gain timely...

Continue Reading
Understanding Market Trends Impacting NCR Atleos Corp's Future

Updated Category News Views 59

Market Sentiment Surrounding NCR Atleos Corp NCR Atleos Corp (NYSE: NATL) has recently caught the attention of investors as its short interest percentage has experienced a notable increase. Currently, approximately 3.76% of the company's shares have been sold short, which translates to about 3.01 million shares. This figure indicates that roughly 6.35% of all regular...

Continue Reading
Leslie’s, Inc. Reports Q2 Fiscal 2025 Earnings and Key Insights

Updated Category News Views 346

Financial Highlights from Leslie’s, Inc. In light of recent developments, Leslie’s, Inc. (NASDAQ: LESL), the premier name in pool and spa care in the U.S., has unveiled its financial results for the second quarter of fiscal year 2025. The company is dedicated to serving both residential and professional customers with quality products and exceptional service. CEO...

Continue Reading